Kavallaris M - Search Results

1

Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment.

Pasquier E, Ciccolini J, Carre M, Giacometti S, Fanciullino R, Pouchy C, Montero MP, Serdjebi C, Kavallaris M, André N. Pasquier E, et al. Among authors: kavallaris m. Oncotarget. 2011 Oct;2(10):797-809. doi: 10.18632/oncotarget.343. Oncotarget. 2011. PMID: 22006582 Free PMC article.

2

Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.

Gan PP, Pasquier E, Kavallaris M. Gan PP, et al. Among authors: kavallaris m. Cancer Res. 2007 Oct 1;67(19):9356-63. doi: 10.1158/0008-5472.CAN-07-0509. Cancer Res. 2007. PMID: 17909044

3

Microtubules: a dynamic target in cancer therapy.

Pasquier E, Kavallaris M. Pasquier E, et al. Among authors: kavallaris m. IUBMB Life. 2008 Mar;60(3):165-70. doi: 10.1002/iub.25. IUBMB Life. 2008. PMID: 18380008 Free article. Review.

4

Microtubules and resistance to tubulin-binding agents.

Kavallaris M. Kavallaris M. Nat Rev Cancer. 2010 Mar;10(3):194-204. doi: 10.1038/nrc2803. Epub 2010 Feb 11. Nat Rev Cancer. 2010. PMID: 20147901 Review.

5

ENMD-1198, a new analogue of 2-methoxyestradiol, displays both antiangiogenic and vascular-disrupting properties.

Pasquier E, Sinnappan S, Munoz MA, Kavallaris M. Pasquier E, et al. Among authors: kavallaris m. Mol Cancer Ther. 2010 May;9(5):1408-18. doi: 10.1158/1535-7163.MCT-09-0894. Epub 2010 May 4. Mol Cancer Ther. 2010. PMID: 20442304

6

Metronomic chemotherapy: new rationale for new directions.

Pasquier E, Kavallaris M, André N. Pasquier E, et al. Among authors: kavallaris m. Nat Rev Clin Oncol. 2010 Aug;7(8):455-65. doi: 10.1038/nrclinonc.2010.82. Epub 2010 Jun 8. Nat Rev Clin Oncol. 2010. PMID: 20531380 Review.

7

γ-Actin regulates cell migration and modulates the ROCK signaling pathway.

Shum MS, Pasquier E, Po'uha ST, O'Neill GM, Chaponnier C, Gunning PW, Kavallaris M. Shum MS, et al. Among authors: kavallaris m. FASEB J. 2011 Dec;25(12):4423-33. doi: 10.1096/fj.11-185447. Epub 2011 Sep 9. FASEB J. 2011. PMID: 21908715

8

Endothelial cell dysfunction and cytoskeletal changes associated with repression of p16(INK4a) during immortalization.

Kan CY, Wen VW, Pasquier E, Jankowski K, Chang M, Richards LA, Kavallaris M, MacKenzie KL. Kan CY, et al. Among authors: kavallaris m. Oncogene. 2012 Nov 15;31(46):4815-27. doi: 10.1038/onc.2011.645. Epub 2012 Feb 6. Oncogene. 2012. PMID: 22310292 Free PMC article.

9

Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells.

Pasquier E, Tuset MP, Street J, Sinnappan S, MacKenzie KL, Braguer D, Andre N, Kavallaris M. Pasquier E, et al. Among authors: kavallaris m. Angiogenesis. 2013 Apr;16(2):373-86. doi: 10.1007/s10456-012-9321-x. Epub 2012 Nov 10. Angiogenesis. 2013. PMID: 23143659 Free PMC article.

10

β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma.

Pasquier E, Street J, Pouchy C, Carre M, Gifford AJ, Murray J, Norris MD, Trahair T, Andre N, Kavallaris M. Pasquier E, et al. Among authors: kavallaris m. Br J Cancer. 2013 Jun 25;108(12):2485-94. doi: 10.1038/bjc.2013.205. Epub 2013 May 21. Br J Cancer. 2013. PMID: 23695022 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

184 results

Search Page